Preclinical studies have shown that ATR is activated following cisplatin treatment and that ATR inhibition can profoundly sensitise tumour cells, including oesophageal cancer cells to platinum-based chemotherapy and radiotherapy [14–17]. The gene discussed is ATR; the disease is neoplasm.